Tag archive for ‘Science Park’
Gil Tanenbaum On Monday, November 17th, 2014

NeuroDerm’s IPO Comes Up Short

– Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, held a less than stellar IPO on the NASDAQ, selling 4.5 million shares More...

Gil Tanenbaum On Monday, November 3rd, 2014

Pharmaceutical NeuroDerm Prepares for NASDAQ IPO

NeuroDerm Ltd., an Israeli clinical stage pharmaceutical company which develops drugs for central nervous system (CNS) diseases, announced the launch of its initial public offering of 4.5 million ordinary More...

Gil Tanenbaum On Tuesday, September 2nd, 2014

Israeli Acne Treating Startup Wants $75 Million in IPO

Israeli startup Foamix Ltd, which makes foams used for drug delivery and has recently developed a new treatment for acne, has announced plans for an IPO in which it expects to raise more than $75 million. More...

Wordpress site Developed by Fixing WordPress Problems